Evidence map›Paper›PMID 38909171›Full record

ReviewDermatology and therapy2024

A Systematic Review and Meta-analysis of Mobile Health Applications and Telemonitoring in Atopic Dermatitis Self-Management.

Ivan Cherrez-Ojeda, Karla Robles-Velasco, María F Osorio, Ana Ormaza Vera, Zouina Sarfraz, Azza Sarfraz, Annia Cherrez, Sofia Cherrez, Jorge Mario Sanchez Caraballo

Abstract readReview
In one paragraph

Review in Dermatology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ivan Cherrez-OjedaUniversidad Espíritu Santo, 0901952, Samborondón, Guayas, Ecuador. ccherrezo@uees.edu.ec.ORCID http://orcid.org/0000-0002-1610-239X
Karla Robles-VelascoUniversidad Espíritu Santo, 0901952, Samborondón, Guayas, Ecuador.
María F OsorioUniversidad Espíritu Santo, 0901952, Samborondón, Guayas, Ecuador.
Ana Ormaza VeraRespiralab Research Group, 090705, Guayaquil, Guayas, Ecuador.
Zouina SarfrazDepartment of Research and Publications, Fatima Jinnah Medical University, Lahore, Pakistan.
Azza SarfrazDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Annia CherrezDepartment of Dermatology and Allergy, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Sofia CherrezGemeinschaftspraxis PD Dr. Jung & Kollegen, Krämpferstr. 6, Erfurt, Germany.
Jorge Mario Sanchez CaraballoGroup of Clinical and Experimental Allergy, Clinic "IPS Universitaria", University of Antioquia, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUp to 25% of children and 5.6% of adults in the USA have atopic dermatitis (AD), with substantial impacts on quality of life. Effective control can be challenging despite therapy efforts. The emergence of information and communication technologies (ICT) in AD management prompted this study to assess its impact on self-management. We conducted a meta-analysis to assess outcomes from peer-reviewed clinical trials evaluating the effectiveness of teledermatology, mobile health (mHealth) apps, and electronic devices for managing AD.

methodsWe searched PubMed, Web of Science, Scopus, and Embase for articles written in English and published until May 2023.

resultsTwelve trials with 2424 participants were selected from 811 studies. A meta-analysis of 1038 individuals reported a mean difference (MD) of -1.57 [95% confidence interval (CI): -2.24, -0.91] for the Patient Oriented Eczema Measure (POEM). A meta-analysis of 495 individuals reported a Dermatology Life Quality Index (DLQI) MD of -0.59 [95% CI: -0.95, -0.23]. Despite heterogeneity (I

conclusionmHealth applications and telemonitoring show significant improvement in patients' quality of life (DLQI) and self-management (POEM) but no significant impact on AD severity (SCORAD).

Indexed as

Atopic dermatitisElectronic devicesmHealth applicationsMobile appsSelf-managementSmart devicesTeledermatologyTelemonitoring

Identifiers

PMID38909171
PMCPMC11264654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.